Purchase by Spiro Rombotis of 6070 shares of Cyclacel Pharmaceuticals
CYCC Stock | USD 0.40 0.02 5.26% |
About 70 percent of all Cyclacel Pharmaceuticals' shareholders are curious in acquiring. The analysis of the overall investor sentiment regarding Cyclacel Pharmaceuticals suggests that quite a large number of traders are confidant. The current market sentiment, together with Cyclacel Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Cyclacel Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Cyclacel |
Filed transaction by Cyclacel Pharmaceuticals director. General open market or private purchase of non-derivative or derivative security
Read at macroaxis.com
Cash Flow Correlation
Cyclacel Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cyclacel Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Cyclacel Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Cyclacel Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cyclacel Pharmaceuticals Fundamental Analysis
We analyze Cyclacel Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cyclacel Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cyclacel Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Cyclacel Pharmaceuticals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Cyclacel Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cyclacel Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Cyclacel Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cyclacel Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Cyclacel Pharmaceuticals Related Equities
CNTB | Connect Biopharma | 7.89 | ||||
PTIX | Protagenic Therapeutics | 5.77 | ||||
IKNA | Ikena Oncology | 1.80 | ||||
SPRO | Spero Therapeutics | 1.75 | ||||
EWTX | Edgewise Therapeutics | 1.15 | ||||
XOMAO | XOMA | 0.40 | ||||
PULM | Pulmatrix | 0.84 | ||||
RZLT | Rezolute | 1.39 | ||||
ELYM | Eliem Therapeutics | 1.90 | ||||
AKTX | Akari Therapeutics | 2.00 | ||||
CTMX | CytomX Therapeutics | 2.48 | ||||
OVID | Ovid Therapeutics | 2.56 | ||||
NXTC | NextCure | 2.59 | ||||
TPST | Tempest Therapeutics | 4.49 | ||||
ASMB | Assembly Biosciences | 6.46 | ||||
MBRX | Moleculin Biotech | 10.47 |
Complementary Tools for Cyclacel Stock analysis
When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
CEOs Directory Screen CEOs from public companies around the world |